Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.85 +0.13 (+1.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Common Equity (2021 - 2026)

Updated

Aspire Biopharma Holdings' Common Equity was $11.76 million in Q2 2026, compared with -$9.62 million a year earlier and up 203.9% from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Common Equity (2021 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Aspire Biopharma Holdings came in at -$6.38 million.

  • In earlier years, Common Equity was -$1.54 million in FY2024, -$487,861 in FY2023, -$9.94 million in FY2022 and -$475.00 in FY2021.
  • The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q1 2021.
  • Per Business Quant data, ASBP's Common Equity in the three quarters before Q2 2026 was $3.87 million (Q1 2026), -$6.38 million (Q4 2025) and -$11.47 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.76 Mn
Mar 31, 2026 3.87 Mn
Dec 31, 2025 -6.38 Mn
Sep 30, 2025 -11.47 Mn
Jun 30, 2025 -9.62 Mn
Mar 31, 2025 -7.95 Mn
Dec 31, 2024 -1.54 Mn
Sep 30, 2024 -774,378.00
Jun 30, 2024 -558,109.00
Mar 31, 2024 -489,747.00
Dec 31, 2023 -487,861.00
Sep 30, 2023 -62,954.00
Jun 30, 2023 261,788.00
Mar 31, 2023 -10.26 Mn
Dec 31, 2022 -9.94 Mn
Sep 30, 2022 -9.62 Mn
Jun 30, 2022 -9.37 Mn
Mar 31, 2022 -9.05 Mn
Dec 31, 2021 -475.00
Sep 30, 2021 280.00
API Access

Aspire Biopharma Holdings, Inc. Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ASBP&period=max&api_key=YOUR_API_KEY